(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasda...pingandcommercializingnovelpainmanagementtherapies...fExecutiveOfficer,isscheduledtopresentatthe21stAnn...er1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork...alOfficer,willbeavailabletorespondtoquestionsdurin...
(Date:11/24/2009)...ndpointhasbeenmetforpatientswithadvanced-stage,orr...4/PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ...ticalcompanyfocusedonendocrinetherapyandoncology,t...ithitstargetedcytotoxicpeptideconjugate,AEZS-108(f...dometrialcancer.Inapersonalizedhealthcareapproach,...
(Date:11/24/2009)...f.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,Inc...icHealth,sExecutiveChairman,willpresentatthe21stAn...nTuesday,December1,2009at10:00a.m.ET. ,, Toacce...tation,visittheInvestorRelationssectionofGenomicHe....Pleaseconnecttothewebsiteatleast15minutespriortot...
(Date:11/24/2009)...RNewswire-FirstCall/--CellTherapeutics,Inc.(CTI)(N...ualPiperJaffrayHealthCareConference.Theconferencew... ,, CTIwillpresentonTuesday,December1at11:00a.m...fCTI,spresentationwillbeavailableat www.celltherap...wards. , ,PiperJaffrayHealthCareConference,NewYor...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2...ref="http://www.ambion.com/catalog/CatNum.php?1632...ere developed for labeling siRNA, they can , .... The following protocol , can be use...f="#visualizing">Visualizing , Introd...dsRNA , labeled in this manner. , ...
...TE THIS ARTICLE: <A , href=..., href="#2">Advantages , ...mitations , > <A , ..., , What is a Nucleas... , Nuclease protection assays...
... with fluorescent , dyes (i.e. Cy3 or... directly incorporated during cDNA synthes...NA reverse transcription (RT) reaction, or attache...performed after any enzymatic reactions , ...e enzymatic , incorporation of a Cy-l...
Other Biology Technology:Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 2Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 3Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 4Nuclease Protection Assays: The Basics 2Nuclease Protection Assays: The Basics 3Nuclease Protection Assays: The Basics 4Nuclease Protection Assays: The Basics 5Nuclease Protection Assays: The Basics 6Nuclease Protection Assays: The Basics 7Nuclease Protection Assays: The Basics 8Nuclease Protection Assays: The Basics 9Nuclease Protection Assays: The Basics 10Amino Allyl Labeling for Array Analysis 2..., ARTICLE #1 FOR IMMEDIATE RELEASE , Potential...rnal of the American Chemical Society , Chemists...ost powerful substance ever discovered for elimina...lead to the world,s first effective medicine for f...ug. Their findings are scheduled for the Sept. 24 ...
... PHILADELPHIA Researchers at Wayne State Universi...mpletely eliminated HER2-positive tumors in mice -...py - without any toxicity. , The study, reported ...journal of the American Association for Cancer Res... HER2-positive, treatment-resistant cancer or help...
... BOSTON--Demonstrating that despite the large numb...y more remain to be found, scientists at Dana-Farb...pected gene, CDK8, to colon cancer. , The discove...ew tools for assessing the activity of specific ge...ols are further improved, the stream of newly disc...
Other Biology News:American Chemical Society's Weekly PressPac -- Sept. 10, 2008 2American Chemical Society's Weekly PressPac -- Sept. 10, 2008 3American Chemical Society's Weekly PressPac -- Sept. 10, 2008 4American Chemical Society's Weekly PressPac -- Sept. 10, 2008 5American Chemical Society's Weekly PressPac -- Sept. 10, 2008 6American Chemical Society's Weekly PressPac -- Sept. 10, 2008 7American Chemical Society's Weekly PressPac -- Sept. 10, 2008 8Vaccine against HER2-positive breast cancer offers complete protection in lab 2Vaccine against HER2-positive breast cancer offers complete protection in lab 3Researchers identify cancer-causing gene in many colon cancers 2BBMVEC (B840-05) from European Collection of Cell Cultures (ECACC)
Adaptor for ABI 3700 (AB-0800) from ABgene
Finnpipette Focus Multichannel 8 channel 5-50l from Thermo Scientific
Plasminogen Activator Inhibitor (PAI-1) Colorimetric Assay Kit from AMERICAN DIAGNOSTICA
Biology Products: